10,885 Shares in Corteva, Inc. (NYSE:CTVA) Bought by Sherbrooke Park Advisers LLC

Sherbrooke Park Advisers LLC purchased a new stake in Corteva, Inc. (NYSE:CTVA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 10,885 shares of the company's stock, valued at approximately $620,000.

Other large investors have also recently bought and sold shares of the company. Van ECK Associates Corp lifted its position in Corteva by 5.9% during the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company's stock worth $537,031,000 after purchasing an additional 525,531 shares during the period. Swedbank AB lifted its position in Corteva by 51.9% during the fourth quarter. Swedbank AB now owns 695,641 shares of the company's stock worth $39,624,000 after purchasing an additional 237,764 shares during the period. Assenagon Asset Management S.A. lifted its position in Corteva by 755.8% during the fourth quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company's stock worth $31,486,000 after purchasing an additional 488,181 shares during the period. JPMorgan Chase & Co. lifted its position in Corteva by 6.7% during the third quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock worth $270,764,000 after purchasing an additional 288,885 shares during the period. Finally, Allworth Financial LP raised its holdings in shares of Corteva by 17.3% during the 4th quarter. Allworth Financial LP now owns 13,699 shares of the company's stock worth $856,000 after buying an additional 2,023 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

Corteva Trading Down 0.5%

NYSE:CTVA traded down $0.35 during mid-day trading on Thursday, hitting $68.61. 799,401 shares of the company's stock were exchanged, compared to its average volume of 3,562,705. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $69.42. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $46.80 billion, a P/E ratio of 53.19, a PEG ratio of 1.68 and a beta of 0.72. The company has a 50 day simple moving average of $62.20 and a 200-day simple moving average of $61.15.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $1.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.88 by $0.25. Corteva had a return on equity of 7.19% and a net margin of 5.36%. The company had revenue of $4.42 billion during the quarter, compared to the consensus estimate of $4.56 billion. During the same period last year, the company earned $0.89 earnings per share. The firm's revenue was down 1.7% compared to the same quarter last year. As a group, research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Monday, June 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.99%. Corteva's payout ratio is currently 41.46%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Royal Bank of Canada boosted their price target on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. BNP Paribas raised Corteva to a "hold" rating in a report on Monday, February 10th. Bank of America boosted their price target on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Wells Fargo & Company boosted their price target on Corteva from $73.00 to $79.00 and gave the stock an "overweight" rating in a report on Monday, May 12th. Finally, The Goldman Sachs Group initiated coverage on shares of Corteva in a research note on Thursday, March 13th. They set a "buy" rating and a $71.00 target price on the stock. One research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $70.50.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.